Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Abigail Zamorano Image

      Abigail Zamorano, MD, MPHS

      Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery

      About Dr. Abigail Zamorano

      Dr. Zamorano is Assistant Professor of Gynecologic Oncology. In addition to providing comprehensive care for patients with gynecologic cancers, including open and minimally invasive surgery and chemotherapy, Dr. Zamorano studies ways to improve clinical outcomes for gynecologic oncology patients. She aims to identify and address disparities in diagnosis, treatment and outcomes using expertise in epidemiology, implementation science, and population health. She co-leads the MD Anderson Cervical Dysplasia Colposcopy program and is an active member of the Society of Gynecologic Oncology, ASCCP, and NRG.

      Read More

      In the News

      Oversized calendar with multiple days shaded in red to depict abnormal bleeding

      When should you worry about abnormal vaginal bleeding?

      Present Title & Affiliation

      Primary Appointment

      Assistant Professor, Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Dual/Joint/Adjunct Appointment

      Assistant Professor, Gynecology Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Licenses & Certifications

      2023American Board of Obstetrics and Gynecologic Gynecologic Oncology subspecialty board certification
      2022American Board of Obstetrics and Gynecology
      2021Texas Medical Board
      2014DEA

      Experience & Service

      Other Professional Positions

      Memeber, International Gynecologic Cancer Society, 2024 - Present

      Member, Cancer Alliance of Texas, Cervical Cancer Screening Subgroup, 2022 - Present

      Member, NRG Oncology, 2021 - Present

      Member, American Society for Colposcopy and Cervical Pathology, 2018 - Present

      Member, American Society of Clinical Oncology, 2018 - Present

      Member, Society of Gynecologic Oncology, 2017 - Present

      Member, American Congress of Obstetricians and Gynecologists, 2014 - Present

      Member, American Medical Association, 2014 - Present

      Extramural Institutional Committee Activities

      Member, SGO Clinical Practice Committee, The Society of Gynecologic Oncology of Canada, 2024 - Present

      Ambassador, SGO 2025 and 2026 Annual Meetings, The Society of Gynecological Oncology, 2024 - 2026

      Member, SGO 2025 Annual Meeting Program Committee, The Society of Gynecologic Oncology of Canada, 2024 - 2025

      Honors & Awards

      2023 - 2024NRG Oncology Early Career and New Investigator Mentored Fellowship
      Center for the Study of Religion Undergraduate Fellow, Princeton University
      Center for the Study of Religion Undergraduate Fellow, Princeton University
      President’s Silver Award for Community Service, UT Southwestern
      Southwestern Gynecologic Assembly Award, UT Southwestern
      ASCCP George C. Trombetta, M.D., Teaching Award
      Washington University in St. Louis “Just in Time” grant recipient
      GOG Foundation New Investigator Award
      Dean’s Teaching Excellence Award, McGovern Medical School at UT Health
      Dean’s Teaching Excellence Award, UT McGovern Medical School
      Dean’s Teaching Excellence Award, UT McGovern Medical School
      National Ovarian Cancer Coalition Quality of Life Research Grant, Foundation for Women’s Cancer

      Grant & Contract Support

      Date: 2026 - 2027
      Title:Understanding Caregiver Burden, Time and Financial Strain, and Non-Medical Drivers of Health Among Ovarian Cancer Patients Foundation for Women’s Cancer, National Ovarian Cancer Coalition Quality of Life Research Grant
      Funding Source:National Ovarian Cancer Coalition
      Role:PI
      Date: 2025 - 2027
      Title:Identifying and Addressing Distress and Unmet Needs of Gynecologic Cancer Caregivers
      Funding Source:Ovarian Cancer Research Alliance (OCRA), Health Equity Grant
      Role:PI
      Date: 2024 - 2027
      Title:The Houston Prevenir, Ayudar, Poder (PAP) Project
      Funding Source:Cancer Prevention and Research Institute of Texas (CPRIT)
      Role:PI
      Date: 2024 - 2025
      Title:The Houston PAP (Prevenir, Ayudar, Poder) Project for Cervical Cancer Screening
      Funding Source:VICTORY
      Role:PI
      Date: 2023 - 2024
      Title:Distress among Caregivers of Patients with Gynecologic Malignancies Undergoing Chemotherapy
      Funding Source:University of Texas Center for Clinical and Translational Sciences (CCTS) Collaborative Pilot Research Award
      Role:PI
      Date: 2022 - 2023
      Title:Exploring the Effect of the COVID-19 Pandemic on Disparities in Cervical Cancer Screening Among Hispanic Women
      Funding Source:Healthy Americas Foundation
      Role:PI
      Date: 2018 - 2019
      Title:NIH-T32 Postdoctoral Fellow in Cancer Prevention and Control
      Funding Source:School of Public Health Sciences, Washington University in St. Louis
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. Amro, FH, Hernandez-Andrade, EA, Papanna, R, Mehl, ST, Kassir, E, Soto-Torres, EE, Chen, HY, Zamorano, A, Guerra, R, Blackwell, S, Sibai, BM. Leaving Placenta In Situ for Management of Placenta Accreta Spectrum Disorder. Obstetrics and gynecology 145(6):683-689, 2025. e-Pub 2025. PMID: 40273455.
      2. Wilke RN, Wu CF, Kanbergs A, Bercow AS, Agusti N, Viveros-Carreno D, Zamorano AS, Rauh-Hain JA, Melamed A. Disparities in facility-level adoption of minimally invasive interval debulking surgery for advanced ovarian cancer. Gynecol Oncol 197:11-18, 2025. e-Pub 2025. PMID: 40250029.
      3. Agusti N, Viveros-Carreno D, Wu CF, Wilke RN, Kanbergs A, Barajas K, Zamorano AS, Pareja R, Melamed A, Rauh-Hain JA. Adjuvant Chemoradiotherapy vs Radiotherapy Alone for Patients With Intermediate-Risk Cervical Cancer. JAMA Oncol 11(5):511-518, 2025. e-Pub 2025. PMID: 40079948.
      4. Kanbergs A, Clapp M, Wu CF, Melamed A, Agusti N, Viveros-Carreno D, Zamorano AS, Virili F, Rauh-Hain JA, Nitecki Wilke R. Cancer diagnosis during pregnancy is associated with severe maternal and neonatal morbidity. Am J Obstet Gynecol 232(5):466.e1-466.e29, 2025. e-Pub 2025. PMID: 39447820.
      5. Kassir E, Hernandez-Andrade EA, Sibai BM, Papanna R, Soto-Torres EE, Coselli JO, Mehl ST, Gerulewicz-Vannini D, Zamorano AS, Blackwell SC, Amro FH. Postpartum Uterine Artery Doppler Indices when Leaving the Placenta In Situ for Placenta Accreta Spectrum. Am J Perinatol 42(15):1998-2005, 2025. e-Pub 2025. PMID: 40157371.
      6. Kanbergs A, Melamed A, Viveros-Carreno D, Wu CF, Wilke RN, Zamorano A, Paladugu K, Havrilesky L, Rauh-Hain JA, Agusti N. Surgical Deescalation Within Gynecologic Oncology. JAMA Netw Open 8(1):e2453604, 2025. e-Pub 2025. PMID: 39775807.
      7. Pennington, K, Pugh, S, Huh, WK, Walker, JL, Jewell, E, Havrilesky, LJ, Carter, J, Muller, CY, Drapkin, R, Lankes, HA, Castellano, T, Zamorano, A, Blank, S, Kachnic, LA. Optimization of Timing for Risk-Reducing Salpingectomy and Oophorectomy. Obstetrics and gynecology 145(1):21-30, 2025. e-Pub 2025. PMID: 39509704.
      8. Viveros-Carreno D, Agusti N, Wu CF, Melamed A, Nitecki Wilke R, Kanbergs A, Pareja R, Zamorano AS, Rauh-Hain JA. Survival After Simple Compared With Radical Hysterectomy for Patients With Early-Stage Cervical Cancer. Obstet Gynecol 145(1):99-107, 2025. e-Pub 2025. PMID: 39326049.
      9. Nguyen, LK, Chung, TH, Le, YC, Reygaerts, H, Olguin, X, Zamorano, A. Hispanic individuals' cervical cancer screening disparities amidst the COVID-19 pandemic. Gynecologic oncology 190:243-249, 2024. e-Pub 2024. PMID: 39243700.
      10. Bissmeyer, MA, Velarde, A, Salazar, AS, Zamorano, A. Use and feasibility of a Lynch Syndrome predictive model for inherited colorectal and endometrial cancer in a low-middle income country. Familial Cancer 23(4):563-567, 2024. e-Pub 2024. PMID: 39317871.
      11. Higgason, N, Nguyen, LK, Le, YC, Juliet Ezeigwe, O, Han Chung, T, Williams, N, Olguin, X, Zamorano, A. Facilitators to cervical cancer screening in a minority, urban, underserved population. Gynecologic Oncology Reports 51, 2024. e-Pub 2024. PMID: 38205237.
      12. Higgason N, Nguyen L, Le YC, Juliet Ezeigwe O, Han Chung T, Williams N, Olguin XK, Zamorano AS. Facilitators to cervical cancer screening in a minority, urban, underserved population. Gynecol Oncol Rep 51:101315, 2024. e-Pub 2024. PMID: 38205237.
      13. Ramphul, R, Zamorano, A, Upadhyay, S, Desai, M, Bauer, CX. Spatiotemporal analysis of HPV vaccination and associated neighborhood-level disparities in Texas—an ecological study. Frontiers in Public Health 12, 2024. e-Pub 2024. PMID: 38983249.
      14. Zamorano, A, Mazul, AL, Marx, CM, Mullen, MM, Greenwade, M, Massad, SL, McCourt, CK, Hagemann, AR, Thaker, PH, Fuh, KC, Powell, MA, Mutch, DG, Khabele, D, Kuroki, LM. Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery. Gynecologic Oncology Reports 44, 2022. e-Pub 2022. PMID: 36217326.
      15. Binder, PS, Hashim, Y, Cripe, JC, Buchanan, TR, Zamorano, A, Vangveravong, S, Mutch, DG, Hawkins, WG, Powell, MA, Spitzer, D. The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer. BMC cancer 22(1), 2022. e-Pub 2022. PMID: 35279106.
      16. Zamorano AS, Wilson EM, Liu J, Leon A, Kuroki LM, Thaker PH, McCourt CK, Fuh KC, Powell MA, Mutch DG, Evanoff BA, Colditz GA, Hagemann AR. Text-message-based behavioral weight loss for endometrial cancer survivors with obesity: A randomized controlled trial. Gynecol Oncol 162(3):770-777, 2021. e-Pub 2021. PMID: 34140179.
      17. Mullen MM, McKinnish TR, Fiala MA, Zamorano AS, Kuroki LM, Fuh KC, Hagemann AR, McCourt CK, Mutch DG, Powell MA, Wildes TM, Thaker PH. A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy. Gynecol Oncol 161(3):700-704, 2021. e-Pub 2021. PMID: 33648746.
      18. Wilson EM, Zamorano AS, Liu J, Morris D, Leon A, Kuroki LM, Thaker PH, McCourt CK, Fuh KC, Powell MA, Mutch DG, Colditz GA, Hagemann AR. Obese endometrial cancer survivors' perceptions of weight loss strategies and characteristics that may influence participation in behavioral interventions. Gynecol Oncol Rep 36:100719, 2021. e-Pub 2021. PMID: 33665293.
      19. Carey-Love A, Mullen MM, Zamorano A, Markovina S, Hagemann AR, Fuh KC, Thaker PH, Mutch DG, Powell MA, Kuroki LM. The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer. Gynecol Oncol Rep 35:100694, 2021. e-Pub 2021. PMID: 33490354.
      20. Zamorano AS, Hagemann AR, Morrison L, Lee JA, Liao LM, Brinton LA, Park Y, Toriola AT. Pre-diagnosis body mass index, physical activity and ovarian cancer mortality. Gynecol Oncol 155(1):105-111, 2019. e-Pub 2019. PMID: 31383570.
      21. Buchanan TR, Zamorano AS, Massad LS, Liu J, Thaker PH, Powell MA, Mutch DG, Kuroki LM. Risk of cervical and vaginal dysplasia after surgery for vulvar intraepithelial neoplasia or cancer: A 6 year follow-up study. Gynecol Oncol 155(1):88-92, 2019. e-Pub 2019. PMID: 31375270.
      22. Sekhon S, Massad LS, Hagemann AR, Dick R, Leon A, Zamorano AS, Thaker PH, McCourt CK, Mutch DG, Powell MA, Kuroki LM. Patients with endometrial cancer continue to lack understanding of their risks for cancer. Gynecol Oncol Rep 29:106-110, 2019. e-Pub 2019. PMID: 31467962.
      23. Zamorano AS, Wan L, Powell MA, Massad LS. Repeating platinum/bevacizumab in recurrent or progressive cervical cancer yields marginal survival benefits. Gynecol Oncol Rep 22:48-51, 2017. e-Pub 2017. PMID: 29234709.

      Editorials

      1. Zamorano AS, Mutch DG. Postpartum salpingectomy: a procedure whose time has come. Am J Obstet Gynecol 220(1):8-9, 2019. PMID: 30591122.

      Abstracts

      1. Buchanan TR, Zamorano AS, Massad LS, Liu J, Thaker PH, Powell MA, Mutch DG, Kuroki LM. Risk of cervical and vaginal dysplasia after surgery for vulvar intraepithelial neoplasia or cancer: A 6 year follow-up study, 2019. e-Pub 2019. PMID: 31375270.
      2. Zamorano AS, Barnoya J, Gharzouzi E, Robbins CC, Orozco E, Guerra SP, Mutch DG. Treatment Compliance as a Major Barrier to Optimal Cervical Cancer Treatment in Guatemala. Western Association of Gynecologic Oncologists Annual Meeting, 2019. e-Pub 2019. PMID: 31067142.
      3. Haydamous J, Cervantes J, Brown AM, Smith AJ, McClelland S, Lucci JA, Nugent EK, Guerra RA, Palavalli Parsons LH, Aviles DA, Smith JA, Rauh-Hain JA, Zamorano AS. Caregiver Distress: Caring for Those Who Care for Our Patients. American Society of Clinical Oncology Annual Meeting.
      4. Haydamous J, Cervantes J, Lucci JA, Nugent EK, Palavalli Parsons LH, Guerra RA, Aviles DA, Smith JA, Zamorano AS. Impact of Social Determinants of Health on Delays in Chemotherapy Initiation for Gynecologic Cancers. American Society of Clinical Oncology Annual Meeting.
      5. Nguy L, Ramphul R, Desai M, Block K, Bauer C, Zamorano AS. Identifying HPV Vaccination Initiation Hot and Cold Spots and Associated Disparities in Texas. Western Association of Gynecologic Oncology Annual Meeting.
      6. Zamorano, Barnoya J, Gharzouzi E, Chrisman Robbins C, Mutch DG. Compliance After Treatment Is a Major Barrier to the Optimal Treatment of Cervical Cancer in Guatemala. Oral presentation, 32nd Annual David Rothman Resident Research Day.
      7. Zamorano AS, Cripe J, Dandulakis M, Huepenbecker S, Schulz R, McCourt CK, Thaker PH, Hagemann AR, Fuh KC, Massad LS, Powell MA, Mutch DG, Kuroki LM. Recommendations for prophylactic granulocyte-colony stimulating factor among advanced stage ovarian cancer patients Does age over 65 really matter?. Society of Gynecologic Oncology 2018 Winter Meeting.
      8. Zamorano AS, Katumba R. Cervical Cancer and HPV: Global Variation of HPV Subtypes and Current Status of the HPV Vaccine. Health and Infectious Disease Annual Conference.
      9. Buchanan T, Cripe J, Zamorano AS, Wang X, Powell MA, Mutch DG, Hawkins W, Spitzer D. Novel targeted TRAIL-based therapy for ovarian cancer using SMAC mimetics as sensitizing agents. Society of Gynecologic Oncology 2019 Annual Meeting.
      10. Zamorano AS, Buchanan T, Liu J, Powell MA, Mutch DG, Thaker PH, Kuroki LM. Risk of Cervical and Vaginal Neoplasia After Intraepithelial Neoplasia or Cancer: A 6-year Follow-up Study. American Society for Colposcopy and Cervical Pathology Annual Meeting.
      11. Zamorano AS, Greenwade M, Mullen MM, Huepenbecker SP, Dandulakis M, Cripe J, Marx MA, Delhi A, Thaker PH, Powell MA, Mutch DG, Kuroki LM. Geographic Disparities and Postoperative Complications in Ovarian Cancer Surgery. Society of Gynecologic Oncology Annual Meeting.
      12. Carillo TM, Salazar AS, Zamorano AS, Ackermann N, Wise PE. Clinical and pathological characterization of colorectal cancer in young adults in Guatemala. Consortium of Universities for Global Health Annual Meeting.
      13. Zamorano AS, Mullen MM, Marx MA, Khabele D, Kuroki LM. Geographic Disparities and Postoperative Complications in Ovarian Cancer Surgery. Society of Black Academic Surgeons Annual Meeting.
      14. Wilson E, Zamorano AS, Liu J, Morris D, Leon A, Kuroki LM, Thaker PH, McCourt CK, Fuh KC, Massad LS, Powell MA, Mutch DG, Khabele D, Colditz G, Hagemann AR. Obese Endometrial Cancer Survivors’ Perceptions of Weight Loss Strategies and Characteristics that May Influence Participation in Behavioral Interventions. Society of Gynecologic Oncology Annual Meeting.
      15. Zamorano AS, Wilson E, Liu J, Kuroki LM, Thaker PH, McCourt CK, Fuh KC, Powell MA, Mutch DG, Khabele D, Colditz G, Hagemann AR. Low Quality of Life and Activity Levels Persist in Obese Endometrial Cancer Survivors Despite Participation in a Behavioral Weight Loss Intervention. Society of Gynecologic Oncology Annual Meeting.
      16. Villanueva M, Ramphul R, Lucci JA, Nugent E, Palavalli Parsons L, Guerra RA, Zamorano AS. A pilot project to increase cervical cancer screening: are we helping the people who actually need it?. Western Association of Gynecologic Oncologists Annual Meeting.
      17. Ge GR, Wilson D, Guerra RA, Zamorano AS. Disparities in breast cancer screening adherence among Hispanic women who receive cervical cancer screening. Gynecologic Oncology Annual Meeting.
      18. Haney K, Nguyen L, Chung TH, Le YC, Reygaerts H, Olguin X, Zamorano AS. Poor Self-Rated Mental Health Affected Cervical Cancer Screening Rates During the COVID-19 Pandemic. Western Association of Gynecologic Oncology Annual Meeting.
      19. Antonioli SH, Das Agarwal N, Chen HY, Coselli JO, Guerra RA, Amro F, Palavalli Parsons LH, Nugent EK, Lucci JA, Sibai BM, Blackwell SC, Zamorano AS. Planned robotic-assisted interval hysterectomy for the management of placenta accreta spectrum. Gynecologic Oncology Annual Meeting.
      20. Zhang CC, Pham T, Jeong J, Guerra RA, Lucci JA, Zamorano AS, Nugent EK, Palavalli Parsons LH. Identifying Barriers to Initiation of Pelvic Floor Therapy Life After Gynecologic Cancer. Western Association of Gynecologic Oncology Annual Meeting.
      21. Nguyen L, Chung TH, Le YC, Reygaerts H, Olguin X, Zamorano AS. Exploring the Effect of the COVID-19 Pandemic on Disparities in Cervical Cancer Screening Among Hispanic Women. Annual Research Meeting Academy Health.
      22. Parker S, Varon M, Thompson E, Foskey T, Suk R, Niu S, Zheng W, Amboree T, Zamorano AS, Montealegre J, Tiro J. Barriers to Cervical Cancer Screening: Results from a State Comprehensive Cancer Control Coalition Survey. ASCCP Scientific Meeting.
      23. Higgason N, Nguyen L, Le YC, Ezeigwe O, Chung TH, Williams N, Olguin XK, Zamorano AS. Facilitators to Cervical Cancer Screening in a Minority, Urban, Underserved Population. Society of Gynecologic Oncology Annual Meeting.
      24. Bissmeyer MA, Velarde A, Zetina Salazar A, Zamorano AS. Use and Feasibility of a Lynch Syndrome Predictive Model for Inherited Colorectal and Endometrial Cancers in Low-Middle Income Countries. Society of Gynecologic Oncology Annual Meeting.
      25. Haney K, Nguyen L, Chung TH, Le YC, Reygaerts H, Olguin X, Zamorano AS. . Effects of the Stress: How PooSelf-Rated Mental Health Affected Cervical Cancer Screening Rates among Hispanic Women During the COVID-19 Pandemic. Society of Gynecologic Oncology Annual Meeting.
      26. Cervantes J, Haydamous J, Aviles D, Lucci JA, Palavalli Parsons L, Guerra R, Nugent E, Zamorano AS. Sociodemographic Factors Associated with Distress among a Diverse Gynecologic Oncology Population. Western Association of Gynecologic Oncology Annual Meeting.
      27. Haydamous J, Cervantes J, Brown AM, Smith AJ, McClelland S, Lucci JA, Aviles DA, Rauh-Hain JA, Zamorano AS. Evaluating Caregiver Distress: Caring for Those Who Care for Our Patients. Western Association of Gynecologic Oncology Annual Meeting.
      28. Haydamous J, Cervantes J, Sammouri J, Brown AM, Smith AJ, McClelland S, Lucci JA, Nugent E, Guerra RA, Palavalli Parsons LH, Aviles DA, Rauh-Hain JA, Zamorano AS. Impact of Social Determinants of Health on Caregiver Distress in Gynecologic Oncology. Society of Gynecologic Oncology Annual Meeting.
      29. Cervantes J, Haydamous J, Sammouri J, Lucci JA, Nugent E, Palavalli Parsons LH, Guerra RA, Aviles DA, Zamorano AS. Social Determinants Driving Distress: Insights from Patients Undergoing Gynecologic Cancer Treatment. Society of Gynecologic Oncology Annual Meeting.
      30. Cervantes J, Sammouri J, Haydamous J, Jeong J, Antonioli SH, Lucci JA, Nugent E, Palavalli Parsons LH, Guerra RA, Aviles DA, Zamorano AS. Barriers to Timely Diagnosis and Treatment of Endometrial Cancer: The Impact of Social Determinants of Health. Walking Tour. Society of Gynecologic Oncology Annual Meeting.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top